Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 417-040-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1995-04-25 to 1995-07-18
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Details on test material:
- Name of test material (as cited in study report): Coagulant 122 (solid)
Substance type: Clear slightly viscous yelow liquid
Physical state: 80.4% solid
Bathc number: 9435262-848
Storate condition of test material: 4°C in the dark. Handled and store under an inert atmosfere.
Constituent 1
Test animals
- Species:
- other: Speific Pathogen Free CD-1 outbred mice
- Strain:
- Swiss
- Sex:
- male/female
Administration / exposure
- Route of administration:
- other: The test substance and negative control were dosed by intraperitoneal injection, and mitomycin C, the positive control compound, orally by intragastric gavage.
- Vehicle:
- Purified water
- Duration of treatment / exposure:
- 24 hours with positive control after dosing
24 or 48 hours with negative control and test substance groups - Post exposure period:
- At the end of the observation period surviving animals were killed and discarded.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Basis:
nominal conc.
All animals in all groups were dosed with the standard volume of 20 ml/kg bodyweight.
- No. of animals per sex per dose:
- Male: 0 mg/kg; No. of animals: 5; Sacrifice time: 24 hours Male: 400 mg/kg; No. of animals: 5; Sacrifice time: 24 hours Male: 800 mg/kg; No. of animals: 5; Sacrifice time: 24 hours Male: 1600 mg/kg; No. of animals: 5; Sacrifice time: 24 hours Male: 0 mg/kg; No. of animals: 5; Sacrifice time: 48 hours Male: 400 mg/kg; No. of animals: 5; Sacrifice time: 48 hours Male: 800 mg/kg; No. of animals: 5; Sacrifice time: 48 hours Male: 1600 mg/kg; No. of animals: 5; Sacrifice time: 48 hours Female: 0 mg/kg; No. of animals: 5; Sacrifice times: 24 hours Female: 400 mg/kg; No. of animals: 5; Sacrifice times: 24 hours Female: 800 mg/kg; No. of animals: 5; Sacrifice times: 24 hours Female: 1600 mg/kg; No. of animals: 5; Sacrifice times: 24 hours Female: 0 mg/kg; No. of animals: 5; Sacrifice times: 48 hours Female: 400 mg/kg; No. of animals: 5; Sacrifice times: 48 hours Female: 800 mg/kg; No. of animals: 5; Sacrifice times: 48 hours Female: 1600 mg/kg; No. of animals: 5; Sacrifice times: 48 hours
- Control animals:
- yes
Examinations
- Tissues and cell types examined:
- Femur bone marrow: proximal epiphysis
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Doses producing toxicity:
In the preliminary test there were 2/4 mortalities at 2000
mg/kg. In addition, in the preliminary and main tests
pilo-erection, ptosis and lethargy were observed at 1600
mg/kg. In the main test there was no significant change in
the ratio of polychromatic to normochromatic erythrocytes.
Observations:
There were no statistically significant increases in the
number of micronucleated erythrocytes at any sampling time.
Any other information on results incl. tables
Preliminary toxicity test:
The detail of any toxic reactions observed are given in Appendix 2a (phase I) and Appendix 2b (phase II) (see attached document).
From the results obtained, the maximum tolerated dose was estimated to be approximately 1600 mg/kg. Dose levels of 400, 800, and 1600 mg/kg were therefore chosen for use in the micronucleus test.
Micronucleus test:
The results of the micronucleus test on Coagulant 122 (solid) at the 24 and 48 hour sampling times are presented in Tables 2 and 3 respectively. Table 1 (in the attached document) gives a summary of the results and the results of statistical analysis. Appendix 4 (in the attached document) summaries the vehicle control micronucleated polychromatic erythrocyte counts obtained in previous, unrelated experiments.
Clinical signs and mortalities
No mortalities were obtained in the micronucleus test.
Clinical signs for animals treated with Coagulant 122 (solid) are detailed in Appendix 3 (in the attached document). No adverse clinical signs were obtained for the vehicle control or positive control treated animals over the duration of the test.
Micronucleated polychromatic erythrocyte counts (mnp)
Coagulant 122 (solid) did not cause any statistically significant increases in the number of micronucleated polychromatic erythrocytes at either sampling [P<0.001 using Wilcoxon's sum of ranks test (Hollander and Wolfe 1973, Langley 1979].
Mitomycin C caused large, highly significant increases (P<0.001) in the frequency of micronucleated polychromatic erythrocytes.
Micronuclead normochromatic erythrocytes. (mnn)
Coagulant 122 (solid) did not cause any substantial increases in the incidence of micronucleated normochromatic erythrocytes at either sampling time.
Ratio of polychromatic to normochromatic erythrocytes (p/n)
Coagulant 122 (solid) failed to cause any signficant decreases in the ratio of polychromatic to normochromatic erythrocytes [P>0.001 using Wilconox´s sum of ranks test (Hollanders and Wolfe 1973, Langley 1979].
Mitomycin C did not cause any statistically signficant decreases in the ration [P>0.01]- it should be noted that even very cytotoxic compounds such as mitomycin C do not always produce a substantial decrease in this ratio as early as the 24 hour sampling time because of the lag caused by erythrocyte maturation (see EVALUATION CRITERIA).
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Since the test substance did not cause any substantial increase in the incidence of micronucleated polychromatic erythrocytes or any substantial decrease in the p/n ratio, it is concluded that Coagulant 122 (solid) did not show any evidence of causing chromosome damage or bone marrow cell toxicity when administrered by intraperitoneal injection in this in vivo test procedure. - Executive summary:
In vivo mammalian cell gene mutation test :
This study was designed to assess the potential induction of micro nuclei by Coagulant 122 (solid) in bone marrow cells of mice. Mice were treated with a single acute intraperitoneal administration of the test substance by injection at a dosage of 400, 800, 1600 mg/Kg. A preliminary toxicity test had previously shown 1600 mg/kg to be approximately the maximum tolerated dosage.
The test substance and negative control were administrated by intraperitoneal injection. The negative control group received the vehicle, purified water. A positive control group was dosed orally, by intragastric gavage, with mitomycin C at 12 mg/kg bodyweight.
Bone marow smears were obtained from five male and five female animals in the negative control and test substance groups at 2 sampling times; these being 24 or 48 hours after dosing. Bone marrow smears were obtained from the positive control group 24hours after dosing. One smear from each animal was examined for the presence of micronuclei in 1000 polychromatic erythrocytes. The ratio of polychromatic to normochromatic erythrocytes was assessed by examination of at least 1000 erythrocytes from each animal. A record of the incidence of micronucleated normochromatic erythrocytes was also kept.
Mice treated with Coagulant 122 (solid) did not show any significant increase in the frequency of micronucleated polychromatic erythrocytes at either sampling time.
There was no significant decrease in the ratio of polychromatic to normochoromatic erythrocytes after treatment of the animals with Coagulant 122 (solid).
The positive control compound, mitomycin C, produced large, highly significant increase in the frequency of micronucleated polychromatic erythrocytes together with decreases in the ratio of polychromatic to normochromatic erythrocytes.
It is concluded that Coagulant 122 (solid) has not shown any evidence of causing chromosome damage in this in vivo test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies